(Q45461871)

14 December 2017

title

Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B. (English)

1 reference

14 December 2017

1 reference

1 reference

1 reference

1 reference

Pei-Jer Chen

4

0 references

author name string

Chih-Lin Lin

1

1 reference

14 December 2017

Li-Ying Liao

2

1 reference

14 December 2017

Chaur-Shine Wang

3

1 reference

14 December 2017

Ming-Yang Lai

5

1 reference

14 December 2017

Ding-Shinn Chen

6

1 reference

14 December 2017

Jia-Horng Kao

7

1 reference

14 December 2017

publication date

1 June 2005

1 reference

14 December 2017

1 reference

14 December 2017

volume

25

1 reference

14 December 2017

issue

3

1 reference

14 December 2017

page(s)

564-570

1 reference

Global control of hepatitis B virus infection.

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01041.X

Hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01041.X

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01041.X

Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01041.X

Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01041.X

Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01041.X

Hepatitis B e antigen and the risk of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01041.X

Epidemiology of hepatitis B virus infection in the Asia-Pacific region

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01041.X

Cirrhosis: new research provides a basis for rational and targeted treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01041.X

Impact of oestrogens on the progression of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01041.X

Hepatitis B virus genotype distribution among chronic hepatitis B virus carriers in Shanghai, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01041.X

Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01041.X

Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01041.X

Hepatitis B viral genotypes: clinical relevance and molecular characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01041.X

Hepatitis B genotypes and the response to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01041.X

Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1478-3231.2005.01041.X

10.1111/J.1478-3231.2005.01041.X

21 January 2018

Identifiers

DOI

1 reference

14 December 2017

1 reference